Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
-
Starton Therapeutics Announces Notice of Allowance for U.S. Patent Application 17/518,930 “Continuous Delivery of Lenalidomide and Other Immunomodulatory Agents” Including Transdermal Administrati
-
Midaxo named a Leader in the IDC MarketScape: Worldwide Mergers and Acquisitions Software 2024 Vendor Assessment
-
NV5 to Host Third Quarter 2024 Conference Call on Thursday, November 7th at 4:30pm ET
-
Locus Unveils Refrigerant Management Software Aligned with the EPA’s Final Rule on Hydrofluorocarbon Phasedown
-
Crowdbotics Unveils Extension for GitHub Copilot to Help Developers Generate More Accurate Code
-
You Could Get Up to $1,300 the Same Day with an H&R Block Emerald Advance® Loan
-
Yoshitsu Co., Ltd Announces Opening of New “Reiwatakiya” Store in Fashion Show Las Vegas, Strengthening U.S. Market Presence
-
CALIFORNIA BANCORP REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2024
-
Tickets For 2025 Formula E Miami E-Prix on Sale Now
-
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Worksport Ltd. Sees Over 200% Growth in B2B Sales; Initiates Pre-Order Campaign for New AL4 Tonneau Cover
-
Kaléo Announces Theresa Matkovits, Ph.D. as Chief Development Officer
-
CTS Announces Third Quarter 2024 Results
-
Immutep Quarterly Activities Report Q1 FY25
-
Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer
-
American Oncology Network (AON) and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform
-
Brooklyn Law School Announces the Michael Simmons and Michael Gerber Professorship
-
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
-
Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development
-
Blackpoint Cyber Launches Global Partner Program and Enablement Platform Emphasizing a Focus on Community and Growth
-
Synchronoss Technologies Announces Third Quarter 2024 Earnings Call Date
-
Duck Creek Technologies Announces 2024 Partner of the Year Award Winners
-
Vast and GGS Energy Partner to Bring CSP-Powered Green Methanol and SAF to the U.S.
-
Safe Harbor Financial Originates $1.07 Million Secured Credit Facility for Missouri Cannabis Operator
-
Talkspace Announces Third Quarter 2024 Results
-
Mattermost Wins “Overall Incident Response Solution of the Year” in 2024 Cybersecurity Breakthrough Awards
-
Gabelli Funds to Host 48th Annual Automotive Symposium at The Encore at Wynn, Las Vegas, Nevada
-
BairesDev Named A Top Development Firm for its Outstanding Client Reviews in 2024
-
Paycor Launches Integration Platform to Transform Connectivity
-
SertifiPay Offers Flexible, All-In-One Options for Hospitality Sales Teams to Maximize Revenue
-
Jennifer Love Hewitt Partners with MakerPlace by Michaels on Exclusive Handmade Holiday Gift Guide
-
Sysco Reports First Quarter Fiscal Year 2025 Results
-
Contract Win
-
Trace One and Covalo Partner to Streamline Product Development for Cosmetics and Personal Care Brands
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
LED Lighting and EV Charging Solutions Provider Orion Previews Q2’25 Results and Updates FY 2025 Outlook in Anticipation of LD Micro Investor Presentation Webcast Today at 8:30 a.m. PT
-
ZyVersa Therapeutics Highlights Review Article Supporting the Need for Drug Therapies to Treat the Inflammation of Obesity in Addition to Weight Loss Drugs
-
Google Chrome leads on Softonic’s most downloaded internet programme ranking for 2024
-
Bybit Card Expands Into New Regions, Offering Seamless and Rewarding International Crypto Payments
-
Praxis Bioresearch Obtains FDA Clearance On the IND Application for Its Lead Candidate PRX-P4-003 In Alzheimer’s Disease Apathy
-
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigat
-
Magnet Recycling Demo Plant Update and Warrant Extension
-
New OREA Whitepaper Offers Bold Policy Recommendations to Raise the Bar for Ontario Real Estate
-
Entrée Resources Announces Commencement of Underground Development on Entrée/Oyu Tolgoi JV Property and Provides Corporate Update
-
DT Midstream Reports Strong Third Quarter 2024 Results; Raises Adjusted EBITDA Guidance
-
ZenaTech Enters the Drone Sensor and Components Market Establishing a New Taiwan Subsidiary to Win More US Defense Contracts for Its AI Drones
-
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
-
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas


